Thamizhanban Pillay | Department of Health, South Africa. Health economics, current policy-maker in Ministry of Health | AFRO | Pharmaceutical Economic Evaluations Department of Health Room no 937 Hallmark Building 231 Proes Street Pretoria South Africa |
Osei B Acheampong | Director of Research and Development, National Health Insurance Authority, Ghana. Current policy-maker | AFRO | National Health Insurance Authority PMB Ministries CDH House, No. 36 Independence Avenue, North Ridge Accra Ghana |
Jaime Espin Balbino | Andalusia School of Public Health. Pharmaceutical policy | AMRO | Universidad de Granada - Escuela Andaluza de Salud Pública Cuesta del Observatorio 4 E-18011 Granada Spain |
David Henry | Institute for Clinical Evaluative Sciences, Canada. Health economics – use of cost-effectiveness | AMRO | Institute for Clinical Evaluative Sciences G1 06, 2075 Bayview Avenue Toronto, ON M4N 3M5 Canada |
Lisa Bero | University of California, San Francisco. Effective Practice & Organization of Care group member, methodologist | AMRO | University of California, San Francisco Department of Clinical Pharmacy 3333 California Street, Suite 420 Box 0613 San Francisco, CA 94118, USA |
Alexandre Lemgruber | Office of Economic Evaluation of Health Technologies, Brazilian Health Surveillance Agency (ANVISA) Current policy-maker | AMRO | ANVISA SIA, Trecho 5, Área Especial 57 Brasília (DF) - CEP 71.205-050 Brazil |
Prashant Yadav | MIT-Zaragoza International Logistics Program, Zaragoza Logistics Center. Supply chain management | EURO | Zaragoza Logistics Center Edificio Náyade 5 C/ Bari 55 - PLAZA 50197 Zaragoza Spain |
Mari Mathiesen | Estonia Health Insurance Fund. Current policy-maker | EURO | Estonia Health Insurance Fund Lembitu 10, 10114 Tallinn Estonia |
Sabine Vogler | Gesundheit Osterreich (Austrian Health Institute). Pharmaceutical pricing | EURO | Gesundheit Osterreich Stubenring 6 1010 Vienna Austria |
Fatima Suleman | School of Pharmacy and Pharmacology, University of KwaZulu-Natal. Pharmaceutical policy | AFRO | School of Pharmacy and Pharmacology University of KwaZulu-Natal South Africa |
Lloyd Sansom | Division of Health Sciences, University of South Australia. Current decision-maker and expert in pharmaceutical policy | WPRO | Chair, Pharmaceutical Benefits Advisory Committee Division of Health Sciences University of South Australia PO Box 2638, Kent Town SA 5071 Australia |
Hu Shanlian | Director, Pharmaco-economic Research and Evaluation Centre. Health insurance, current policy-maker | WPRO | Pharmaco-economic Research and Evaluation Centre School of Public Health Fudan University 138 Yi Xue Yuan Road Shanghai 200032 China |
Sauwakon Ratanawijitrasin | Secretary General, Pharmaceutical System Research and Development Foundation (PhaReD), Thailand. Health insurance and pharmaceutical policy | SEARO | Pharmaceutical System Research & Development Foundation (PhaReD) 121 Anantanak Road Pomprab District Bangkok 10100 Thailand |
Salmah Bahri | Director, Pharmacy Practice and Development Division Pharmaceutical Services Division, Ministry of Health, Malaysia. Pharmaceutical policy | WPRO | Pharmacy Practice and Development Division Pharmaceutical Services Division Ministry of Health Malaysia Jalan Universiti, 46350 Petaling Jaya, Selangor Malaysia |
Sudip Chaudhuri | Indian Institute of Management Calcutta | | Indian Institute of Management Calcutta Joka, Kolkata 700 104 India |
Mohammed Abuelkhair | Section Head, Drugs and Medical Products Regulation, Health Authority – Abu Dhabi | | Health Authority – Abu Dhabi Airport Road P.O. Box 5674 Abu Dhabi United Arab Emirates |
WHO Steering Group |
---|
Clive Ondari – Essential Medicines and Health Products, Medicines Access and Rational Use (EMP/MAR) – Coordinator, MAR Alexandra Cameron – EMP/MAR - Selection Unit Suzanne Hill – EMP/MAR – Selection Unit (currently Chair of the Australian Pharmaceutical Benefits Advisory Committee, see below) Maryam Bigdeli – Access to Medicines Policy Research, Alliance for Health Policy and Systems Research (HSR/HSS) Zafar Mirza – Public Health, Innovation and Intellectual Property Kees de Joncheere – Regional Adviser, EURO |
External consultant |
---|
Patricia Whyte – Deakin University, Australia |